Cosmos Health (COSM) CEO swaps $45K company debt for stock

Rhea-AI Filing Summary

Cosmos Health Inc. filed a Form 4 showing that CEO, director and 10% owner Grigorios Siokas acquired additional common shares through a debt-for-equity exchange. On January 23, 2026, he obtained 90,325 shares of common stock at $0.4982 per share, representing the fair market value that day, in exchange for $45,000 of debt the company owed him under a Debt Exchange Agreement. Following this transaction, he directly holds 8,182,120 common shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Siokas Grigorios

(Last) (First) (Middle)

5 AG. GEORGIOU STR., PILEA

(Street)

THESSALONIKI J3 TK57001

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cosmos Health Inc. [ COSM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $.001	01/23/2026	01/23/2026	P(1)		90,325	A	$0.4982	8,182,120	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to a debt exchange agreement by and between Grigorios Siokas, the Company's CEO and the Company (the "Debt Exchange Agreement"), dated as of January 23, 2026, these shares are Exchange Shares (as defined in the Debt Exchange Agreement) being acquired by Mr. Siokas at the Exchange Rate (as defined in the Debt Exchange Agreement) of $0.4982 per share, the fair market value of the Common Stock on January 23, 2026, in exchange for a total amount of $45,000 in debt the Company owed to Mr. Siokas.

Remarks:

	/s/ Grigorios Siokas	01/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did COSM report for Cosmos Health's CEO?

Cosmos Health Inc. reported that CEO, director and 10% owner Grigorios Siokas acquired 90,325 shares of common stock in a debt-for-equity exchange on January 23, 2026.

How many Cosmos Health (COSM) shares did the CEO acquire and at what price?

Grigorios Siokas acquired 90,325 Cosmos Health common shares at $0.4982 per share, which the filing identifies as the fair market value on January 23, 2026.

What was exchanged for the new COSM shares acquired by the CEO?

The shares were issued under a Debt Exchange Agreement, cancelling $45,000 of debt that Cosmos Health owed to Grigorios Siokas in return for common stock at the stated exchange rate.

How many Cosmos Health shares does the CEO own after this Form 4 transaction?

After the reported transaction, Grigorios Siokas directly owns 8,182,120 shares of Cosmos Health common stock.

Is the Cosmos Health CEO considered a major insider based on this filing?

Yes. The Form 4 identifies Grigorios Siokas as a director, Chief Executive Officer, and a 10% owner of Cosmos Health Inc.

Was this COSM insider transaction a market purchase or a structured exchange?

Although coded as a purchase, the filing explains it was a debt exchange, where the CEO received shares in lieu of $45,000 the company owed him, at $0.4982 per share.